Skip to main content
    I

    Inogen Inc (INGN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $5.63
    -0.06 (-1.05%)

    Market Cap: $147.95M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Inogen Inc (INGN) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Inogen (INGN) to earn -$0.29 per share in the fiscal year ending Dec 31, 2026, on revenue of $311.30M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.36.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates fall 1.1%.

    Fiscal year ending Dec 31, 2026
    -$0.29
    EPS consensus, revenue $311.30M
    Fiscal year ending Dec 31, 2027
    -$0.36
    EPS consensus, revenue $307.95M

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.29-$0.29 to -$0.291$311.30M$299.20M to $323.40M2
    Dec 31, 2027-$0.36-$0.36 to -$0.361$307.95M$307.90M to $308.00M2

    Quarterly Estimates

    The EPS consensus falls from -$0.18 for the quarter ending Dec 31, 2026 to -$0.23 for the quarter ending Mar 31, 2027.

    EPS range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.18-$0.19 to -$0.174$85.68M$81.14M to $89.46M4
    Mar 31, 2027-$0.23-$0.25 to -$0.202N/AN/A0

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 1 upward and 4 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202701
    Quarter ending Mar 31, 202712

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.28.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.29-$0.28-$0.28-$0.28-$0.28N/A
    Fiscal year ending Dec 31, 2027-$0.36-$0.16-$0.16-$0.16-$0.16N/A
    Quarter ending Mar 31, 2027-$0.23-$0.21-$0.21-$0.21-$0.19N/A

    Frequently Asked Questions About INGN

    What is the INGN stock forecast?

    Consensus analyst estimates put Inogen's EPS at -$0.29 for the fiscal year ending Dec 31, 2026, on revenue of $311.30M.

    What EPS do analysts expect from INGN next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.29, with estimates from -$0.29 to -$0.29 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.36, with estimates from -$0.36 to -$0.36 from 1 analyst.

    What revenue do analysts expect from Inogen next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $311.30M, with estimates from $299.20M to $323.40M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $307.95M, with estimates from $307.90M to $308.00M.

    How many analysts cover INGN?

    1 analyst estimates EPS for Inogen for the fiscal year ending Dec 31, 2026.